Connection

SUZANNE FUQUA to Ligands

This is a "connection" page, showing publications SUZANNE FUQUA has written about Ligands.
Connection Strength

0.195
  1. A hypersensitive estrogen receptor alpha mutation that alters dynamic protein interactions. Breast Cancer Res Treat. 2010 Jul; 122(2):381-93.
    View in: PubMed
    Score: 0.069
  2. Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer. Clin Cancer Res. 2004 Nov 15; 10(22):7490-9.
    View in: PubMed
    Score: 0.049
  3. Estrogen receptor and breast cancer. Semin Cancer Biol. 2001 Oct; 11(5):339-52.
    View in: PubMed
    Score: 0.039
  4. Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells. Am J Pathol. 2009 Sep; 175(3):1270-80.
    View in: PubMed
    Score: 0.017
  5. Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions. J Biol Chem. 2001 Jul 27; 276(30):27907-12.
    View in: PubMed
    Score: 0.010
  6. Coexpression of wild-type and variant oestrogen receptor mRNAs in a panel of human breast cancer cell lines. Br J Cancer. 1995 May; 71(5):974-80.
    View in: PubMed
    Score: 0.006
  7. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen. Breast Cancer Res Treat. 1993; 26(3):237-46.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.